Cowen & Company Initiates ACADIA Pharmaceuticals At Outperform

By: via Benzinga
Cowen & Company initiated coverage on shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) with a Outperform rating. The target price for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.